Archive for the ‘Lupus’ Category

Antibodies Linked To Cardiovascular Disease Increase In Patients With Active Lupus

A study by researchers in Australia and the United Kingdom suggests that autoantibodies to fat binding proteins significantly increase in systemic lupus erythematosus (SLE) patients with active disease...

Lupus Patients Perceive Benefit From Cardiovascular Disease Prevention Counseling Program

According to a new study by Hospital for Special Surgery investigators presented at the American College of Rheumatology meeting on October 21 in Philadelphia, most lupus patients are not aware that their condition puts them at a higher risk for cardiovascular disease and a counseling program is a valuable way to promote education and lifestyle change.

Lupus Drug Benlysta Effective In Phase 3 Trials

In what has been described as the first lupus drug in decades to show effectiveness in phase 3 clinical trials, the announcement that Benlysta (belimumab) outperformed placebo has surprised Wall Street, where many had assumed the drug was going nowhere.